Wednesday, June 25, 2014 8:23:52 AM
By Emma Crawford Hampel
Tue Jun 24, 2014 9:23am PST
Sirona Biochem Corp. president Neil Belenkie is resigning from his position as CEO, the company announced June 23.
Sirona’s CFO Christopher Hopton told Business in Vancouver that Belenkie decided to resign because as the company has evolved, its needs changed.
“He felt he was no longer a good fit,” Hopton said
Belenkie will remain with the company until July 18. An executive search is on for Belenkie’s replacement, said Hopton.
Howard Verrico, Sirona’s founder and chairman, will act as interim CEO.
Belenkie has been CEO of Sirona Biochem since October 2012. He is also the CEO and co-founder of the GrowthPoint Group and an alumnus of Harvard, Queen’s, the University of Calgary and Mount Royal University.
Belenkie was a winner of Business in Vancouver’s Forty under 40 in 2011.
ecrawford@biv.com
@EmmaHampelBIV
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM